From: Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
IC50 μg/ml (RI) | |||
---|---|---|---|
HMEC-1 | HMECd1 | HMECd2 | |
Doxorubicin | 0.0028 ± 0.0003 (1) | 0.1 ± 0.027 (35.7) * | 0.5 ± 0.01 (178.5) * |
Daunorubicin | 0.018 ± 0.009 (1) | 0.92 ± 0.01 (51.1) * | 1.7 ± 0.78 (94.4) * |
Vinblastine | 0.023 ± 0.007 (1) | 0.16 ± 0.03 (69.5) * | 0.2 ± 0.03 (86.9) * |
Etoposide | 0.0031 ± 0.0006 (1) | 0.062 ± 0.0062 (20) * | 0.6 ± 0.094 (203.5) * |
Mytomycin C | 0.16 ± 0.0074 (1) | 0.15 ± 0.071 (0.9) | 0.18 ± 0.0003 (1.1) |